日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Excessive accumulation of visceral fat is associated with lower urinary symptoms including overactive bladder in female patients

内脏脂肪过度堆积与女性患者的下尿路症状（包括膀胱过度活动症）有关。

期刊:International Journal of Urology
影响因子:2.2
doi:10.1111/iju.14476
Otsubo, Asato; Miyata, Yasuyoshi; Matsuo, Tomohiro; Mukae, Yuta; Mitsunari, Kensuke; Ohba, Kojiro; Sakai, Hideki
发表日期：2021
文献求助 收藏

Presurgical bladder wall thickness is a useful marker to predict the postsurgical improvement of symptoms in patients with pelvic organ prolapse-related overactive bladder

术前膀胱壁厚度是预测盆腔器官脱垂相关膀胱过度活动症患者术后症状改善情况的有用指标。

期刊:Luts-Lower Urinary Tract Symptoms
影响因子:1.5
doi:10.1111/luts.12374
Otsubo, Asato; Matsuo, Tomohiro; Miyata, Yasuyoshi; Mukae, Yuta; Mitsunari, Kensuke; Ohba, Kojiro; Sakai, Hideki
发表日期：2021
文献求助 收藏

Present Status, Limitations and Future Directions of Treatment Strategies Using Fucoidan-Based Therapies in Bladder Cancer

基于岩藻聚糖的疗法在膀胱癌治疗中的现状、局限性及未来方向

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers12123776
Miyata, Yasuyoshi; Matsuo, Tomohiro; Ohba, Kojiro; Mitsunari, Kensuke; Mukae, Yuta; Otsubo, Asato; Harada, Junki; Matsuda, Tsuyoshi; Kondo, Tsubasa; Sakai, Hideki
肿瘤
肿瘤免疫
膀胱癌
发表日期：2020
文献求助 收藏

Pathological roles of c-Met in bladder cancer: Association with cyclooxygenase-2, heme oxygenase-1, vascular endothelial growth factor-A and programmed death ligand 1

c-Met在膀胱癌中的病理作用：与环氧合酶-2、血红素加氧酶-1、血管内皮生长因子-A和程序性死亡配体1的关联

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2020.11540
Mukae, Yuta; Miyata, Yasuyoshi; Nakamura, Yuichiro; Araki, Kyohei; Otsubo, Asato; Yuno, Tsutomu; Mitsunari, Kensuke; Matsuo, Tomohiro; Ohba, Kojiro; Sakai, Hideki
肿瘤
心血管
膀胱癌
肿瘤免疫
发表日期：2020
文献求助 收藏

Efficacy of Tadalafil Therapy and Changes in Oxidative Stress Levels in Male Patients with Lower Urinary Tract Symptoms and Overactive Bladder.

他达拉非治疗对男性下尿路症状和膀胱过度活动症患者氧化应激水平的影响及疗效

期刊:Luts-Lower Urinary Tract Symptoms
影响因子:1.5
doi:10.1111/luts.12283
Matsuo Tomohiro, Miyata Yasuyoshi, Araki Kyohei, Mukae Yuta, Otsubo Asato, Ohba Kojiro, Sakai Hideki
其它
氧化应激
发表日期：2020
文献求助 收藏

Erratum: Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial

更正：口服蜂王浆可通过调节肾细胞癌中的TNF-α和TGF-β来增强抗癌效果并抑制分子靶向治疗的不良反应：一项基于随机双盲临床试验的初步研究

期刊:Molecular and Clinical Oncology
影响因子:1.4
doi:10.3892/mco.2020.2148
Miyata, Yasuyoshi; Araki, Kyohei; Ohba, Kojiro; Mastuo, Tomhiro; Nakamura, Yuichiro; Yuno, Tsutomu; Mukai, Yuta; Otsubo, Asato; Mitsunari, Kensuke; Mochizuki, Yasushi; Sakai, Hideki
TGF-β
发表日期：2020
文献求助 收藏

Four-weekly Low-dose Gemcitabine and Paclitaxel in Patients With Platinum-resistant Urothelial Cancer and Performance Status 2/3

对铂类耐药尿路上皮癌且体能状态评分为 2/3 的患者，每四周进行一次低剂量吉西他滨和紫杉醇治疗。

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.11725
Araki, Kyohei; Miyata, Yasuyoshi; Nakamura, Yuichiro; Mukae, Yuta; Otsubo, Asato; Yuno, Tsutomu; Mitsunari, Kensuke; Matsuo, Tomohiro; Ohba, Kojiro; Sakai, Hideki
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏